Proxy Biomedical Announces Expansion
Irish medical implantable devices manufacturer to double cleanroom facilities as part of expansion that will be completed in the second quarter of 2016.
., Galway, is adding 3000-ft2 of additional cleanroom space rated to Class 8/ 100,000 to support production of new products, according to a company spokesperson, a move that effectively doubles its cleanroom manufacturing space. Proxy declined to reveal the total amount of investment.
Among the products launched in 2015 which are prompting the expansion are resorbable and non-resorbable biomaterials for vascular indication; Proxy Bio-XT, a proprietary process that reinforces resorbable implants for applications including soft tissue fixation in orthopaedics; and ProTEX Med polypropylene, a custom synthesized resin with a FDA Master File reference.
Proxy’s plastics processing capabilities include compression molding, injection molding, lamination and multi-axial laser processing. The company also has what it describes as a number of systems for resorbable polymer material quality control and characterization.
Related Content
-
Krones Acquires Netstal
Krones adds PET preform injection molding to its bottle blowing and filling capabilities, as well as cap molding and expansion into medical, food and other markets.
-
Medical Molder, Moldmaker Embraces Continuous Improvement
True to the adjective in its name, Dynamic Group has been characterized by constant change, activity and progress over its nearly five decades as a medical molder and moldmaker.
-
Digital Manufacturing: Two Medical Molders Embrace Industry 4.0
‘Digitalization’ and ‘connectivity’ are loaded terms—shorthand for a whole new way of doing 911爆料网. It can’t be accomplished in one go. But two Midwest molders in the sensitive medical field are already feeling the benefits of their initial steps in that direction.